Sugi Predict

Sugi Predict / Compounds / SCHEMBL16436342

SCHEMBL16436342

SCHEMBL16436342

C=C(C)C(=O)Oc1ccc(-c2ccc(-c3cc(F)c4cc(OC(=O)C(=C)C)ccc4c3)o2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.38
▸ ATM Q13315 1/20 0.38
▸ ELANE P08246 1/20 0.38
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ NQO2 P16083 4/20 0.34
▸ GAPDH P04406 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CA12 O43570 2/20 0.32
▸ CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16436317 0.85 ELANE (0.44) KMT2AATMELANENQO2GAPDH
SCHEMBL16436320 0.84 ELANE (0.36) KMT2AATMELANENQO2GAPDH
SCHEMBL16436385 0.83 ELANE (0.44) KMT2AATMELANENQO2GAPDH
SCHEMBL16436315 0.82 ELANE (0.42) KMT2AATMELANENQO2KDM4E
SCHEMBL16436196 0.81 ELANE (0.53) KMT2AATMELANENQO2KDM4E
SCHEMBL16436233 0.81 ELANE (0.41) KMT2AATMELANENQO2GAPDH
SCHEMBL16436349 0.81 ELANE (0.41) KMT2AATMELANENQO2GAPDH
SCHEMBL16939663 0.80 KMT2A (0.43) KMT2AATMELANEESR1ESR2
SCHEMBL16436429 0.80 ELANE (0.47) KMT2AATMELANENQO2KDM4E
SCHEMBL16436272 0.80 ELANE (0.40) KMT2AATMELANENQO2GAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315603-B2 Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2016-04-19 — — US disclosed
US-9315603-B2 Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2016-04-19 — — US disclosed
US-20150034871-A1 POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2015-02-05 — — US disclosed
US-20150034871-A1 POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2015-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150034871-A1 POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE OCIAD1, OCIAD2, SCO2 KMT2A 3863/4885ATM 4113/4885ELANE 2946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.